Stock Analysis on Net
Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Paying users area

Try for free

Moderna Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Moderna Inc., consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Product sales
Cost of sales
Gross profit
Grant revenue
Collaboration revenue
Research and development
Selling, general and administrative
Income (loss) from operations
Interest income
Gain (loss) on investments
Interest expense
Other income (expense), net
Other income (expense), net
Income (loss) before income taxes
(Provision for) benefit from income taxes
Net income (loss)
Premium paid on repurchase of preferred stock
Cumulative preferred stock dividends
Reconciliation of net income (loss) to net income (loss) attributable to common stockholders
Net income (loss) attributable to common stockholders

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Income statement item Description The company
Product sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Moderna Inc. product sales increased from 2020 to 2021 and from 2021 to 2022.
Income (loss) from operations The net result for the period of deducting operating expenses from operating revenues. Moderna Inc. income (loss) from operations increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Income (loss) before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Moderna Inc. income (loss) before income taxes increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Moderna Inc. net income (loss) increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.